Skip to main content

Table 1 Demographics

From: Assessing the clinical utility of genetic risk scores for targeted cancer screening

Sex
 Male 94 (33.45%)
 Female 187 (66.55%)
Age
 40–49 56 (19.93%)
 50–59 94 (33.45%)
 60–70 131 (46.62%)
Race
 Caucasian 267 (95.02%)
 African American 9 (3.2%)
 East Asian 5 (1.78%)
Family history
 Breast cancer Missing: 13
  Male 30 (34.09%)
  Female 69 (38.33%)
 Prostate cancer Missing: 12
  Male 24 (26.67%)
  Female 47 (26.26%)
 Colorectal cancer Missing: 8
  Male 23 (25.56%)
  Female 49 (26.78%)